Warren R E, Brewerton D A
Ann Rheum Dis. 1980 Feb;39(1):37-44. doi: 10.1136/ard.39.1.37.
In consecutive samples submitted to a clinical microbiology laboratory 22 out of 99 from outpatients and 23 out of 51 from inpatients yielded Klebsiella sp. A clinical reassessment of outpatients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA) who had not been inpatients within the last year was made for disease activity and drug requirements. 124 patients with AS and 92 with RA were requested at assessment to submit a stool specimen for klebsiella examination, this being carried out without disclosure of the patient's clinical category. Two months later a questionnaire on symptom changes was collected and the results correlated with klebsiella carriage. Eighty-nine patients with AS and 82 patients with RA fulfilled all criteria for assessment. Of those assessed, 24 out of 89 AS patients and 26 out of 82 RA patients had klebsiella in the faeces. There was no correlation betweeh the initial clinical assessment category and klebsiella carriage. Seventy patients with AS and 57 paients with RA had no change in symptoms over the 2-month period. Nineteen AS patients and 31 RA patients noted symptom improvement or worsening. Of these, 3 AS and 10 RA patients had klebsiella in their faeces. There was no correlation between worsening of symptoms over a 2-month period and klebsiella carriage at initial assessment.
在提交给临床微生物学实验室的连续样本中,99名门诊患者中有22名、51名住院患者中有23名检出克雷伯菌属。对过去一年未曾住院的强直性脊柱炎(AS)和类风湿关节炎(RA)门诊患者进行了疾病活动度和药物需求的临床重新评估。在评估时,要求124名AS患者和92名RA患者提交粪便标本进行克雷伯菌检测,检测过程中不告知患者的临床分类。两个月后,收集了关于症状变化的问卷,并将结果与克雷伯菌携带情况进行关联。89名AS患者和82名RA患者符合所有评估标准。在这些接受评估的患者中,89名AS患者中有24名、82名RA患者中有26名粪便中含有克雷伯菌。初始临床评估类别与克雷伯菌携带情况之间无相关性。70名AS患者和57名RA患者在2个月期间症状无变化。19名AS患者和31名RA患者症状有改善或恶化。其中,3名AS患者和10名RA患者粪便中含有克雷伯菌。2个月期间症状恶化与初始评估时克雷伯菌携带情况之间无相关性。